ArticleInternational urology and nephrology2013

Plasma cell-free DNA and its DNA integrity as biomarker to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate-specific antigen.

Jiang Feng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.